Atlas Trials

Phathom Pharmaceuticals, Inc.

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Phathom Pharmaceuticals, Inc.

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks (NCT07752407)Phathom Pharmaceuticals, Inc.2026-09-25
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks (NCT06851559)Phathom Pharmaceuticals, Inc.2025-10-30
A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants (NCT06831344)Phathom Pharmaceuticals, Inc.2025-02-14
A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily (NCT06391177)Phathom Pharmaceuticals, Inc.2024-05-07
A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease (NCT06106022)Phathom Pharmaceuticals, Inc.2023-11-01
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease (NCT05343364)Phathom Pharmaceuticals, Inc.2022-05-09
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) (NCT05195528)Phathom Pharmaceuticals, Inc.2022-01-17
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NCT04799158)Phathom Pharmaceuticals, Inc.2021-03-25
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants (NCT04729101)Phathom Pharmaceuticals, Inc.2021-01-28
Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants (NCT04545944)Phathom Pharmaceuticals, Inc.2020-09-15
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis (NCT04124926)Phathom Pharmaceuticals, Inc.2019-10-28

Track Phathom Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.